Newsletter Introduction: Unmasking the Truth Behind Vaccine Safety

In a world where trust in public health hangs by a thread, what if the most critical questions about childhood vaccines—questions that could rewrite our understanding of safety and long-term health—were deliberately buried for nearly two decades? Imagine a groundbreaking study, conducted by one of America’s most respected medical institutions, revealing stark differences in chronic illnesses between vaccinated and unvaccinated children. Now, after years of suppression, that inconvenient truth is finally breaking free.

Enter “An Inconvenient Study”, the explosive new documentary that just premiered on October 12, 2025, exposing the hidden saga of a Henry Ford Hospital research project sidelined since 2004. This isn’t just a film—it’s a seismic shift in the vaccine debate, narrated with unflinching clarity by vaccine skeptics like Del Bigtree and backed by raw data that challenges the status quo. As headlines scream about outbreaks and mandates, this video dares to ask: What have we not been told, and at what cost to our kids?

In this edition, we dive deep into the revelations of “An Inconvenient Study,” unpack its implications for parents, policymakers, and the medical establishment, and explore how you can join the growing chorus demanding transparency. Buckle up—the truth is more powerful than any shot.

Synopsis: “An Inconvenient Study”

“An Inconvenient Study” (2025) is a riveting investigative documentary that uncovers the suppression of a pivotal 2004 Henry Ford Hospital study comparing long-term health outcomes in vaccinated versus unvaccinated children. Led by infectious disease expert Dr. Paul Thomas and championed by the Informed Consent Action Network (ICAN), the film reveals how the study—showing significantly higher rates of chronic conditions like allergies, asthma, and neurodevelopmental disorders in the vaccinated cohort—was buried amid pressure from pharmaceutical interests and regulatory bodies.

Through exclusive interviews, declassified documents, and expert testimony from figures like Del Bigtree of The Highwire, the 90-minute feature traces the study’s 20-year fight for sunlight, culminating in its public release in 2025. It spotlights the human cost: families grappling with unexplained illnesses and a healthcare system prioritizing profits over prevention. Premiering amid renewed global scrutiny on vaccine policies, this film isn’t just a critique—it’s a call to action for unredacted science and informed choice. Available now at aninconvenientstudy.com.

ANY ASSERTIONS BY ICAN OR ANYONE OUTSIDE OF THE HENRY FORD HEALTH SYSTEM MADE IN THIS FILM REGARDING THE REASONS HENRY FORD OR ITS EMPLOYEES TOOK OR DID NOT TAKE ANY ACTION ARE OPINIONS BASED ON THE FACTS DETAILED HEREIN.

FOR MORE INFORMATION, PLEASE VISIT ANINCONVENIENTSTUDY.COM

THIS COULD CHANGE EVERYTHING

In 2016, journalist Del Bigtree issued a challenge to the head of infectious disease at one of the most prestigious medical institutions in the world: conduct the most thorough vaxxed vs. unvaxxed study that has ever been done. The expert took up the challenge and ran the study to prove Del wrong. That study never saw the light of day... until now.

SUPPORT THIS FILM

Your gift will not only support the production of the film but also play a crucial role in its successful release and distribution. Please help us spread the word far and wide.

Donate: Click Here

Please share this Newsletter with your interested friends:

Red Alinsod, MD (red@gynflix.com)

www.alinsodinstitute.com

JOIN DR. ALINSOD’S CLINICAL STUDY: I need 10 Volunteers

Alinsod Institute Has Moved to Arlington, Texas!

Dear Friends, Patients, and Colleagues,

I’m thrilled to share some exciting news with you! After years of serving our patients at the Alinsod Institute in Dallas, we’ve relocated to a beautiful new home in Arlington, Texas. This move is all about making your experience with us even better, and I can’t wait to welcome you to our new space. You can find us at www.alinsodinstitute.com, and I’m eager to share why this change is so special.

Why Arlington?

We chose Arlington for its unbeatable convenience. Nestled just minutes from Dallas Fort Worth International Airport (DFW), our new location makes it a breeze for patients flying in from across the country or even internationally. With an array of hotels nearby, your visit—whether for a consultation, procedure, or follow-up—will be as seamless as possible. Arlington places us right in the heart of America, and I like to think of it as the Center of Cosmetic Gynecology for the United States. It’s the perfect spot to continue our mission of transforming lives through innovative care.

A Legacy of Care and Innovation

For the past 30 years, I’ve dedicated my practice to helping women feel confident, comfortable, and empowered. My focus has been on labiaplasty,vaginoplasty, vaginal rejuvenation, and pelvic reconstructive surgery, with a special emphasis on Revision Surgeries for those seeking to correct less-than-ideal outcomes from prior procedures. It’s been a privilege to develop techniques like the Barbie Look Labiaplasty, Hybrid Look Labiaplasty, Curvilinear Labia Majoraplasty, and in-office, no-IV labiaplasty and vaginoplasty—approaches that prioritize comfort and natural results.

I’m also humbled to have invented tools that make these procedures safer and more precise, including the Lone Star APS Vaginal Retractor, Alinsod Surgical Stand, and specialized scissors, clamps, and forceps. My work with ThermiVa, a groundbreaking radiofrequency treatment for feminine restoration, and Predictive Permeation for gynecologic conditions has opened new doors for non-surgical solutions. It’s all about giving you options that fit your needs and lifestyle.

Beyond the operating room, I’m proud to serve as the Founder, Editor, and Director of Gynflix.com, the premier online e-learning platform for cosmetic gynecology. For 20 years, I’ve had the honor of training dozens of Alinsod Fellows worldwide, sharing techniques that blend artistry and science to elevate patient care.

Dr.